The distributed Actiwatch Spectrum Plus devices were originally classified by Respironics as a Class I rule 12 medical devices using the classifications rules for medical devices found in schedule 1 of the Medical Device Regulations. As indicated by Health Canada, the device was deemed to be a Class II device requiring a license prior to product distribution.